当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析

冠昊生物

(300238)

  

流通市值:25.24亿  总市值:25.24亿
流通股本:2.65亿   总股本:2.65亿

冠昊生物(300238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.15亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益47165.41万元,未分配利润-33108.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产69236.80万元,负债22071.39万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入91,441,252.36404,178,697.25308,949,013.47210,814,871.09
营业总成本71,751,172.33360,489,232.61258,011,428.97178,230,785.37
营业利润20,520,473.3933,988,561.844,354,392.3833,850,036.43
利润总额20,480,417.8832,089,194.4643,983,016.4933,893,615.23
净利润15,474,779.8421,072,537.5238,132,984.5530,205,873.76
其他综合收益-80,925.934,244,210.952,670,524.541,215,900.12
综合收益总额15,393,853.9125,316,748.4740,803,509.0931,421,773.88
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计274,841,498.16267,277,868.72309,399,989.17316,139,084.88
非流动资产合计417,526,458.27411,317,030.68371,031,096.74366,622,328.83
资产总计692,367,956.43678,594,899.4680,431,085.91682,761,413.71
流动负债合计149,429,777.9172,716,216.73161,917,940.2173,011,120.69
非流动负债合计71,284,078.8749,618,436.9246,829,544.1947,448,426.71
负债合计220,713,856.77222,334,653.65208,747,484.39220,459,547.4
归属于母公司股东权益合计534,904,427.93520,593,839.11529,252,060.58517,269,486.06
股东权益合计471,654,099.66456,260,245.75471,683,601.52462,301,866.31
负债和股东权益合计692,367,956.43678,594,899.4680,431,085.91682,761,413.71
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计99,050,081.27444,178,639.41334,839,021.52222,868,937.42
经营活动现金流出小计88,179,541.29390,028,811.48274,941,449.79187,522,768.46
经营活动产生的现金流量净额10,870,539.9854,149,827.9359,897,571.7335,346,168.96
投资活动现金流入小计-2,808,5716,541500
投资活动现金流出小计34,622,805.3653,918,68624,036,700.719,813,689.03
投资活动产生的现金流量净额-34,622,805.36-51,110,115-24,030,159.71-9,813,189.03
筹资活动现金流入小计24,000,00037,500,00025,500,000-
筹资活动现金流出小计8,209,683.3164,824,101.1256,070,570.4118,358,897.18
筹资活动产生的现金流量净额15,790,316.69-27,324,101.12-30,570,570.41-18,358,897.18
汇率变动对现金及现金等价物的影响-26,824.2777,012.71-581,264.03472,343.03
现金及现金等价物净增加额-7,988,772.96-24,207,375.484,715,577.587,646,425.78
期末现金及现金等价物余额88,119,632.5196,108,405.47131,248,680.45127,962,206.73
最新报告期:2024-03-09
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
西南证券杜向阳0.220.310.372024-03-09
TOP↑